News
Orrick Welcomes the Partner Class of 2024
8 minute read | January.23.2024
Orrick’s 10 new partners reflect the firm’s focus on tech, life sciences, energy and finance, and include six litigators.
8 minute read | January.23.2024
Orrick’s 10 new partners reflect the firm’s focus on tech, life sciences, energy and finance, and include six litigators.
January.18.2023
Orrick advised SFJ on its acquisition of assets related to the drug Bentracimab from PhaseBio.
March.25.2022